Jiayu Li

发表

Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer

Ningning Cheng, Jiayu Li, Ke Fei, 2015, Oncotarget.

PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases

Caicun Zhou, G. Gao, Xue-Fei Li, 2020, OncoTargets and therapy.

No increase in delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: a meta-analysis of RCTs

P. Liang, Bin, Q. Guo, 2019 .

PD-1/L1 With or Without CTLA-4 Inhibitors Versus Chemotherapy in Advanced Non-Small Cell Lung Cancer

W. Ren, Jiayu Li, Danqi Chen, 2022, Cancer control : journal of the Moffitt Cancer Center.

The safety and efficacy of immunotherapy with anti-programmed cell death 1 monoclonal antibody for lung cancer complicated with Mycobacterium tuberculosis infection

S. Ren, Caicun Zhou, G. Gao, 2021, Translational lung cancer research.

Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer

Guohua Yang, S. Ren, Caicun Zhou, 2020, Annals of translational medicine.

Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients.

Bing Li, S. Ren, Caicun Zhou, 2012, Lung cancer.

Correlation between thymidylate synthase gene polymorphisms and efficacy of pemetrexed in advanced non-small cell lung cancer

Caicun Zhou, G. Gao, Xue-Fei Li, 2012, Experimental and Therapeutic Medicine.

Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors

T. Jiang, S. Ren, Caicun Zhou, 2020, Translational lung cancer research.

The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancer

T. Jiang, S. Ren, Caicun Zhou, 2020, Translational lung cancer research.

Two Updates on Oesophagogastric Junction Adenocarcinoma from the Fifth WHO Classification of Tumors of the Digestive System: Alteration of Definition and Emphasis on HER2 Test.

Jiayu Li, Yunzhu Li, Manji Li, 2020 .

The New Role of Cytomorphology from Ultrasound-Guided Fine Needle Aspiration Cytology in Evaluating the Status of Prognostic Factors Including Estrogen Receptor, Progesterone Receptor and HER2 in Breast Cancer

Jiayu Li, Yunzhu Li, Shijun Jia, 2021 .

Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer

Guohua Yang, S. Ren, Caicun Zhou, 2019, Annals of Translational Medicine.

Two updates on adenocarcinoma of gastroesophageal junction from the fifth WHO classification of tumors of the digestive system: alteration of gastroesophageal junction definition and the emphasis on HER2 test.

Jiayu Li, Yunzhu Li, Manji Li, 2020 .

Programmable DNA-Fueled Electrochemical Analysis of Lung Cancer Exosomes.

Fan Yang, Jiayu Li, Ya Cao, 2022, Analytical chemistry.

Analysis of Driver Mutations in Female Non-Smoker Asian Patients with Pulmonary Adenocarcinoma

S. Ren, Caicun Zhou, Jiayu Li, 2012, Cell Biochemistry and Biophysics.

Serum Levels of the Cancer-Testis Antigen POTEE and Its Clinical Significance in Non-Small-Cell Lung Cancer

Wa Cao, Ningning Cheng, Jiayu Li, 2015, PloS one.

Efficacy of ICIs on patients with oncogene-driven non-small cell lung cancer: a retrospective study

Jiayu Li, A. Xiong, H. Du, 2022, Cancer drug resistance.

Analysis of Driver Mutations in Female Non-Smoker Asian Patients with Pulmonary Adenocarcinoma

S. Ren, Caicun Zhou, Jiayu Li, 2012, Cell Biochemistry and Biophysics.

Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19

S. Ren, Caicun Zhou, G. Gao, 2020, Translational lung cancer research.

Epithelial phenotype as a predictive marker for response to EGFR‐TKIs in non‐small cell lung cancer patients with wild‐type EGFR

Guotong Xu, S. Ren, Caicun Zhou, 2014, International Journal of Cancer.

Prognostication of Pancreatic Cancer Using The Cancer Genome Atlas Based Ferroptosis-Related Long Non-Coding RNAs

Weiyan Chen, Jiayu Li, Yuyan Zhang, 2022, Frontiers in Genetics.

Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples

S. Ren, Caicun Zhou, Xue-Fei Li, 2014, Translational oncology.

High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.

S. Ren, Caicun Zhou, Ningning Cheng, 2015, International journal of clinical and experimental pathology.

Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer—an option for overcoming EGFR-TKI resistance

Xiaozhen Liu, Donglai Chen, Caicun Zhou, 2021, Translational lung cancer research.

Hepatic metastasis is a poor predictive marker for erlotinib in lung adenocarcinoma.

S. Ren, Caicun Zhou, Jiayu Li, 2016, Medical hypotheses.

Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2nd/3rd Line Therapy in Patients with Lung Adenocarcinoma

F. Hirsch, C. Rivard, D. Chan, 2016, Medical science monitor : international medical journal of experimental and clinical research.

Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancer.

S. Ren, Caicun Zhou, Ningning Cheng, 2015, Oncology reports.

Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients

S. Ren, Caicun Zhou, Ningning Cheng, 2014, Translational oncology.

Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations

S. Ren, Caicun Zhou, G. Gao, 2020, Frontiers in Oncology.

EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism.

F. Hirsch, Jing Zhao, T. Jiang, 2018, Lung cancer.

The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non–small cell lung cancer

F. Hirsch, S. Ren, Caicun Zhou, 2014, Cancer.

Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never‐smoker women with pulmonary adenocarcinoma

S. Ren, Caicun Zhou, G. Schmid‐Bindert, 2012, Cancer.

Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF

S. Ren, Caicun Zhou, Xue-Fei Li, 2019, Cancer medicine.

Long non-coding RNA UCA 1 induces non-T 790 M acquired resistance to EGFR-TKIs by activating the AKT / mTOR pathway in EGFR-mutant non-small cell lung cancer

F. Hirsch, Xiaoxiang Chen, S. Ren, 2015 .

Nuclear Morphological Characteristics in Breast Cancer: Correlation with Hormone Receptor and Human Epidermal Growth Factor Receptor 2

Jiayu Li, Yunzhu Li, Yang Liu, 2021, Analytical Cellular Pathology (Amsterdam).

Comparison of gastrojejunostomy to endoscopic stenting for gastric outlet obstruction: An updated Systematic Review and Meta-analysis.

Jiayu Li, Jingjie Chen, Nannan Du, 2021, American journal of surgery.

Exosomes transmit T790M mutation‐induced resistance in EGFR‐mutant NSCLC by activating PI3K/AKT signalling pathway

Xiaozhen Liu, T. Jiang, S. Ren, 2020, Journal of cellular and molecular medicine.

Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M.

T. Jiang, S. Ren, Caicun Zhou, 2019, Lung cancer.

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

F. Hirsch, C. Rivard, S. Ren, 2016, OncoTargets and therapy.

Histone deacetylation, as opposed to promoter methylation, results in epigenetic BIM silencing and resistance to EGFR TKI in NSCLC.

Caicun Zhou, Ningning Cheng, W. Cai, 2017, Oncology letters.

The Novel Role of Cytomorphology from Ultrasound-Guided Fine Needle Aspiration Cytology in Evaluating the Status of Prognostic Factors including Estrogen Receptor, Progesterone Receptor and HER2 in Breast Cancer

Jiayu Li, Yunzhu Li, Shurong Li, 2022, Analytical cellular pathology.

MiR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type

F. Hirsch, S. Ren, Caicun Zhou, 2014, Oncotarget.

Programmable DNA Circuit-Facilitated Determination of Circulating Extracellular Vesicle PD-L1 for Lung Cancer Diagnosis and Immunotherapy Response Prediction.

Caicun Zhou, Jiayu Li, Wei Li, 2023, ACS applied materials & interfaces.

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure

J. Zhao, Juan Zhou, S. Ren, 2019, Thoracic Cancer.

Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer.

Xiaozhen Liu, Caicun Zhou, Haoyue Guo, 2023, European journal of cancer.

A nomogram for the prediction of the survival of patients with advanced non‐small cell lung cancer and interstitial lung disease

Caicun Zhou, Jiayu Li, Yuwen Zhou, 2023, Cancer medicine.

Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusion

Jingyun Shi, T. Jiang, S. Ren, 2020, Translational lung cancer research.

Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC

F. Hirsch, Hui Yu, Jing Zhao, 2017, Theranostics.

T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients.

Jingyun Shi, S. Ren, Caicun Zhou, 2014, Lung cancer.

Impact of family history of cancer on the incidence of mutation in epidermal growth factor receptor gene in non-small cell lung cancer patients.

S. Ren, Caicun Zhou, G. Gao, 2013, Lung cancer.

Two updates on oesophagogastric junction adenocarcinoma from the fifth WHO classification: Alteration of definition and emphasis on HER2 test.

Yunzhu Li, Jiayu Li, Jiman Li, 2020, Histology and histopathology.

Epithelial phenotype as a predictive marker for response to EGFR‐TKIs in non‐small cell lung cancer patients with wild‐type EGFR

Guotong Xu, S. Ren, Caicun Zhou, 2014, International journal of cancer.

Oncotargets and Therapy Dovepress Dovepress Comparison of Erlotinib and Pemetrexed as Second-/ Third-line Treatment for Lung Adenocarcinoma Patients with Asymptomatic Brain Metastases

C. Rivard, S. Ren, Caicun Zhou, 2022 .